Overview Phase 2a Study of IW-9179 to Treat Functional Dyspepsia Status: Terminated Trial end date: 2014-03-01 Target enrollment: Participant gender: Summary The objectives of this study are to determine the safety and efficacy of IW-9179 administered to patients with functional dyspepsia (FD). Phase: Phase 2 Details Lead Sponsor: Ironwood Pharmaceuticals, Inc.